Details for New Drug Application (NDA): 009175
✉ Email this page to a colleague
The generic ingredient in FURADANTIN is nitrofurantoin. There are twenty drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the nitrofurantoin profile page.
Summary for 009175
Tradename: | FURADANTIN |
Applicant: | Casper Pharma Llc |
Ingredient: | nitrofurantoin |
Patents: | 0 |
Suppliers and Packaging for NDA: 009175
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
FURADANTIN | nitrofurantoin | SUSPENSION;ORAL | 009175 | NDA AUTHORIZED GENERIC | Rising Pharma Holdings, Inc. | 16571-740 | 16571-740-24 | 1 BOTTLE in 1 CARTON (16571-740-24) / 230 mL in 1 BOTTLE |
FURADANTIN | nitrofurantoin | SUSPENSION;ORAL | 009175 | NDA AUTHORIZED GENERIC | Rising Pharma Holdings, Inc. | 16571-888 | 16571-888-06 | 1 BOTTLE in 1 CARTON (16571-888-06) / 60 mL in 1 BOTTLE |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | SUSPENSION;ORAL | Strength | 25MG/5ML | ||||
Approval Date: | Approved Prior to Jan 1, 1982 | TE: | AB | RLD: | Yes |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | SUSPENSION;ORAL | Strength | 50MG/5ML | ||||
Approval Date: | Jun 9, 2023 | TE: | RLD: | Yes |
Complete Access Available with Subscription